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INTRODUCTION
Apoptosis is generally characterized by its 
distinct morphological characteristics such 
shrinkage of cells, segmentation of nucleus, 
condensation, and cleavage of DNA into 
domain-sized fragment in most cells followed 
by nucleolus degradation (Wagstaff and Jans, 
2009).  These characteristics of cell death may be 
identified easily in histological sections stained 
with haematoxylin and eosin (H&E) reagents. 
The identification and counting of apoptotic 
cells in the H&E staining have been extensively 
used to study apoptosis induced by radiation or 
other cytotoxic agents for many years (Matsuu-
Matsuyama et al., 2008).  This stain is also 
excellent for displaying tissue morphology, but 
insufficient to distinguish between the apoptotic 
and necrotic cells.  Thus, powerful tools, such 
as transmission electron microscopy (TEM), are 
needed to solve this matter.  In addition, TEM is 
especially used to distinguish between apoptotic 
and necrosis in oncolytic cell population, as these 
processes may share common features (Miller et 
al., 2002).  Normally, apoptotic cells have intact 
membranes and organelles, as well as condensed 
nuclear membrane fragments.  Therefore, many 
references found on the subject of apoptosis 
were appropriately observed and recorded by 
using the TEM equipment (Wyllie et al., 1999; 
Blankenberg et al., 2000).
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ABSTRACT
The process of cell death, or apoptosis, is commonly defined by its distinct morphological characteristic. 
Apoptosis is considered a vital component of various processes including normal cell turnover, proper 
development and functioning of the immune system, the cellular antiviral response pathway, embryonic 
development and chemical-induced cell death.  In this study, retroviral vector was utilized as the gene delivery 
vehicles and the tumour-specific viral death effector VP3 as pro-apoptotic agent for malignant colon cancer 
cells treatment.  Here, pro-apoptotic gene inducing apoptosis in CT26 colon tumour cells is reported.  In 
addition, the activation of a typical apoptotic programme was observed in response to this therapeutic agent. 
An increased number of colon tumour cells suffered apoptosis upon treatment with pro-apoptotic agent.  As a 
result, these tumour cells displayed loss of membrane asymmetry and impermeability, cell shrinkage, nuclear 
condensation and DNA fragmentation under H&E images.  In the presence of VP3, TEM also confirmed that 
VP3-treated CT26 tumour cells showed apoptotic features.  These results suggested that VP3 was a potential 
pro-apoptotic agent and the apoptosis induced by VP3 was a key anti-tumour mechanism.
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In the present study, a recombinant of 
retroviral vector containing pro-apoptotic gene 
(VP3 gene) was used.  VP3 which is also known 
as apoptin is a 14-kDa basic protein derived 
from the chicken anemia virus (CAV) that can 
induce apoptosis in transformed and malignant 
cell lines (De Smit and Noteborn, 2009).  This 
pro-apoptotic gene was predominantly found 
in the cytoplasm, whereas in transformed and 
tumour cells, it was located in the nucleus, 
suggesting that the location of apoptin is related 
to its activity (Los et al., 2009).
The present study focused on determining 
VP3 induced apoptosis in light microscopic 
assessment and ultrastructure of tumour cells in 
vivo level.  This particular study also concentrated 
on our studies with CT26 tumour-bearing mice. 
Apoptosis induced by VP3 in the treated tumour 
was analyzed using the H&E staining and TEM 
analysis.  This combination of H&E staining 
and TEM application would provide us with a 
powerful approach to obtain useful information 
about the image of tumour cells, and to explain 
the results at the ultrastructural level.
MATERIALS AND METHODS
Cell Culture and Reagents
CT26 cells obtained from the ATCC were grown 
in high-glucose RPMI6410 (Gibco, USA) 
supplemented with 10% fetal bovine serum 
(FBS; Gibco, USA), penicillin (Gibco, USA) 
and streptomycin (Gibco, USA).  Meanwhile, 
retrovirus packaging cell lines, PT67 cells from 
ATCC, were maintained in high-glucose DMEM 
medium supplemented with 10% FBS.
Transfection and Virus Production
The recombinant retrovirus of pMSCV-VP3 
was transfected into PT67 packaging cells by 
Calcium Phosphate Transfection System (BD 
Biosciences Clontech, USA).  The culture 
media were replaced after 12 h to remove the 
calcium phosphate and residual DNA.  Stably 
transfected cells were selected in a medium 
containing 50 mg/mL neomycin (Sigma, USA). 
Pooled colonies of transfected cells were allowed 
to grow to confluency, and viral supernatant 
harvested, following overnight incubation 
in serum-free DMEM for infections.  All the 
supernatants were filtered (0.45 μm) for further 
step.
In vivo Experiments in Mice Model
Balb/c mice at five weeks of age were kept at 
constant temperature in 12 h circadian cycles. 
They were provided with standard rodent 
chow and water ad libitum.  For induction of 
tumour, 1.0 × 106 CT26 mouse colon carcinoma 
cells in 200 μl of phosphate buffered-saline 
were subcutaneously injected into the right 
flank of each mouse.  The appearance time of 
palpable tumour was recorded, and the longest 
perpendicular diameters were measured twice 
weekly using callipers.  Tumours were allowed 
to grow for 7-10 days prior to administration 
of recombinant retrovirus particles.  A total of 
250 µl (3 × 104) of the retroviral supernatants, 
produced as described above, were administrated 
to the tumour-bearing mice.  Mice were sacrificed 
48 h post-treatment, at which time small pieces 
of tumour tissues were then removed for 
histopatological processing and TEM analysis.
Histopathology
Subcutaneous tumour tissues were fixed 
overnight in fresh buffered 4% paraformal-
dehyde, and subsequently processed through 
a serial of alcohol dehydration, chlorate, 
and paraffinization.  All of the tissues were 
embedded in paraffin and sectioned at 3 µm.  All 
slides were stained with hematoxylin-eosin and 
examined microscopically.
Transmission Electron Microscopic (TEM)
The tissues were also particularly observed by 
the TEM in following procedure.  They were cut 
into small pieces (2-4 mm) and fixed in 2.5% 
glutaraldehyde in 0.1 M PBS (pH 7.2) at 4°C 
for 4 h.  The tissues were then rinsed with cold 
PBS and post-fixed in 1% osmium tetroxide 
at room temperature for another 2 h.  After 
dehydration with gradient ethanol and twice with 
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acetone for 15 min each time, the samples were 
embedded in resin and acetone (1:1) for 30 min, 
followed by 100% resin for 1 h.  Finally, resin 
was solidified at 37°C for 24 h and at 60°C for 
another 48 h.  Ultrathin sections were obtained 
and subsequently stained with uranyl acetate and 
lead citrate for examination by TEM.
RESULTS AND DISCUSSION
Histopathology
Apoptosis and tumour cell death in response 
to cytotoxic drug i.e., pro-apoptotic gene was 
normally assessed by monitoring the appearance 
of typical nuclear morphological changes and 
internucleosomal DNA cleavage.  In this study, 
Balb/c mice were sacrificed after 48 h of the last 
injection of recombinant retroviral supernatants. 
The anti-tumour effect of VP3-expressing tissues 
in cellular biology was histophatologically 
observed using the H&E staining.  In VP3-
treated tumours, the induction of apoptosis by 
VP3 was confirmed by the cytomorphological 
features, which include nuclear condensation, 
rounded dark nucleic, presence of interstitial 
space and formation of apoptotic bodies (Fig. 1). 
Similar characteristics of the morphological 
changes of cells undergoing apoptosis have been 
reported (Pulkkanen et al., 2002; Natesan et al., 
2006; Pietersen et al., 1999).
TEM
For further determination of apoptosis response 
in subcutaneous tumour, the samples were 
evaluated using the TEM analysis, which is 
the best method for morphological observation 
through clearly differentiating nucleic and 
organelle.  It is important to note that this 
approach is normally used to distinguish and 
confirm the presence of different alterations 
affecting tumour cells due to apoptosis or 
necrosis (Reid et al., 2003).  The ultrastructures 
of the morphological changes during apoptosis 
were also seen, including the reduction in volume 
of the nucleus, condensed nuclear material and 
nuclear membrane blebbing, all of which could 
be found in VP3-treated tumours (Fig. 2). 
Supporting this was the presence of some intact 
organelles in the cytoplasm.  In addition, these 
data showed that the administration of retroviral-
mediated VP3 gene was able to induce apoptosis 
in tumour cells.
CONCLUSIONS
In conclusion, these data clearly demonstrated 
that cancer cells response against VP3 was 
predominantly found in nuclear membrane 
with distinctive morphological features. 
This investigation is also worthy for further 
consideration as a move approach in the 
treatment of solid tumours.
Control VP3
Fig. 1: Apoptotic effect of pro-apoptotic gene; VP3 on subcutaneous tumour at the cellular 
level (arrows).  CT26 tumour tissue was isolated from mice treated with pro-apoptotic gene 
(right panel) or control (left-panel) (H&E, x 200)
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Fig. 2: TEM profiles showed control (A) and VP3-infected cancer cells (B&C).   
A: Ultrastructure of control tumour cells (× 5500); B: Note the demonstrated nuclear 
blebs (arrow) (x 12500); C: The features of apoptosis showed the shrinkage of nuclear 
membrane which had become smaller (arrows) (x 7700)
